___
Her family history is noted for both parents living father age 
___ with history of coronary artery disease s/p MI with 
angioplasties and stents, prostate and bladder CA; mother with 
no significant health issues; paternal grandfather deceased at 
the age of ___ with acute MI. 
 
Physical Exam:
T=98.2F; BP=131/85mmHg; HR=64x'; RR=18x'; O2 Sat=94% Ra
 GENERAL: AOx3, NAD
 HEENT: Normocephalic, atraumatic. 
 CARDIAC: Regular rate and rhythm, no murmurs/rubs/gallops.  
 LUNGS: No respiratory distress. Clear to auscultation 
bilaterally. No wheezes, rhonchi or rales. 
 ABDOMEN:  Normal bowel sounds, non distended, non-tender to 
palpation. Incisions appear well healed, without erythema or 
secretions
 EXTREMITIES: No clubbing, cyanosis, or edema. 
 
Pertinent Results:
___ 04:18AM BLOOD Hct-37.3
___ 05:11PM BLOOD Hct-40.1
 
Brief Hospital Course:
___ is a ___ woman with class
III morbid obesity and BMI of 49.3 and co-morbidities of
hypertension, obstructive sleep apnea on CPAP, pre-diabetes and
history of gallstones s/p laparoscopic cholecystectomy. She has
been unsuccessful at achieving sustained weight loss by 
non-operative means. After evaluation from our multidisciplinary 
team she was deemed an excellent candidate for laparoscopic 
gastric sleeve. She presented to ___ on ___ for this 
elective procedure.
The patient presented to pre-op on ___ and was evaluated 
by anaesthesia. The patient was taken to the operating room for 
a laparoscopic sleeve gastrectomy. There were no adverse events 
in the operating room; please see the operative note for 
details. Pt was extubated, taken to the PACU until stable, then 
transferred to the ward for observation. 
 Neuro: The patient was alert and oriented throughout 
hospitalization; pain was initially managed with a PCA. Pain was 
very well controlled. The patient was then transitioned to 
crushed oral pain medication once tolerating a stage 3 diet. 
 CV: The patient remained stable from a cardiovascular 
standpoint; vital signs were routinely monitored. 
 Pulmonary: The patient remained stable from a pulmonary 
standpoint; vital signs were routinely monitored. Good pulmonary 
toilet, early ambulation and incentive spirometry were 
encouraged throughout hospitalization. 
 GI/GU/FEN: The patient was initially kept NPO. Afterwards, the 
patient was started on a stage 1 bariatric diet, which the 
patient tolerated well. Subsequently, the patient was advanced 
to stage 2, and then stage 3 diet which the patient was 
tolerating on day of discharge. 
 ID: The patient's fever curves were closely watched for signs 
of infection, of which there were none. 
 HEME: The patient's blood counts were closely watched for signs 
of bleeding, of which there were none. 
 Prophylaxis: The patient received subcutaneous heparin and ___ 
dyne boots were used during this stay and was encouraged to get 
up and ambulate as early as possible. 
 At the time of discharge, the patient was doing well, afebrile 
and hemodynamically stable. The patient was tolerating a 
bariatric stage 3 diet, ambulating, voiding without assistance, 
and pain was well controlled. The patient received discharge 
teaching and follow-up instructions with understanding 
verbalized and agreement with the discharge plan. 
 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. phentermine 37.5 mg oral ASDIR 
2. Valsartan 80 mg PO DAILY 
3. Triamcinolone Acetonide 0.1% Ointment 1 Appl TP ASDIR 
4. Ketoconazole 2%  1 Appl TP ASDIR 
5. MetFORMIN (Glucophage) 500 mg PO DAILY 
6. Ferrous Sulfate 325 mg PO ASDIR 
7. pedi multivit 43-iron fumarate 18 mg iron oral DAILY 
8. Cyanocobalamin 1000 mcg PO DAILY 
9. Vitamin D 1000 UNIT PO DAILY